Skip to content

China Grants Approval for Pfizer’s Antiviral Covid Pill

  • Paxlovid is first foreign Covid-19 treatment approved by China
  • Regulator requires unspecified conditional requirements
Boxes of Pfizer Inc.’s Paxlovid antiviral medication. 
Boxes of Pfizer Inc.’s Paxlovid antiviral medication. Photographer: Kobi Wolf/Bloomberg
Updated on

Sign up for Next China, a weekly email on where the nation stands now and where it's going next.

China granted emergency approval for Pfizer Inc.’s Covid-19 pill in a promising sign the country could open up further to foreign vaccines and treatments for the virus.